Trial Profile
Persistence and adherence of fingolimod versus other disease modifying therapies in patients with multiple sclerosis: A Retrospective US Claims Database Analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Glatiramer acetate; Interferon; Natalizumab
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 26 May 2015 New trial record